A method to confer Protein L binding ability to any antibody fragment

abstract Recombinant antibody single-chain variable fragments (scFv) are difficult to purify homogeneously from a protein complex mixture. The most effective, specific and fastest method of purification is an affinity chromatography on Protein L (PpL) matrix. This protein is a multi-domain bacterial surface protein that is able to interact with conformational patterns on kappa light chains. It mainly recognizes amino acid residues located at the VL FR1 and some residues in the variable and constant (CL) domain. Not all kappa chains are recognized, however, and the lack of CL can reduce the interaction. From a scFv composed of IGKV10-94 according to IMGT®, it is possible, with several mutations, to transfer the motif from the IGKV12-46 naturally recognized by the PpL, and, with the single mutation T8P, to confer PpL recognition with a higher affinity. A second mutation S24R greatly improves the affinity, in particular by modifying the dissociation rate (kd). The equilibrium dissociation constant (KD) was measured at 7.2 10-11 M by surface plasmon resonance. It was possible to confer PpL recognition to all kappa chains. This protein interaction can be modulated according to the characteristics of scFv (e.g., stability) and their use with conjugated PpL. This work could be extrapolated to recombinant monoclonal antibodies, and offers an alternative for protein A purification and detection.

[1]  I. Kurnaz.  Protein Production and Purification , 2015 .

[2]  N. Aubrey,et al.  Diabody Mixture Providing Full Protection against Experimental Scorpion Envenoming with Crude Androctonus australis Venom , 2012, The Journal of Biological Chemistry.

[3]  M. Bouabdelli,et al.  Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential. , 2011, Analytical biochemistry.

[4]  F. Laraba-Djebari,et al.  Grafting of protein L-binding activity onto recombinant antibody fragments. , 2009, Analytical biochemistry.

[5]  Marc Graille,et al.  Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response. , 2005, Journal of molecular biology.

[6]  Dipankar Das,et al.  Comparative evaluation of two purification methods of anti-CD19-c-myc-His6-Cys scFv. , 2005, Protein expression and purification.

[7]  Marie-Paule Lefranc,et al.  IMGT, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[8]  S. Bottomley,et al.  Observation and Characterization of the Interaction between a Single Immunoglobulin Binding Domain of Protein L and Two Equivalents of Human κ Light Chains* , 2004, Journal of Biological Chemistry.

[9]  H. Rochat,et al.  Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin , 2003, Cellular and Molecular Life Sciences CMLS.

[10]  M. Taussig,et al.  Evidence for Plasticity and Structural Mimicry at the Immunoglobulin Light Chain-Protein L Interface* , 2002, The Journal of Biological Chemistry.

[11]  S. Bottomley,et al.  Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. , 2001, Structure.

[12]  E. Moreau,et al.  Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector. , 2001, European journal of biochemistry.

[13]  S. Bottomley,et al.  Interactions between a single immunoglobulin-binding domain of protein L from Peptostreptococcus magnus and a human kappa light chain. , 1999, The Biochemical journal.

[14]  M. Mousli,et al.  A recombinant single‐chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector , 1999, FEBS letters.

[15]  M. Lefranc,et al.  Unique database numbering system for immunogenetic analysis. , 1997, Immunology today.

[16]  Andrew C. R. Martin,et al.  Accessing the Kabat antibody sequence database by computer , 1996, Proteins.

[17]  L. Björck,et al.  Purification of antibodies using protein L-binding framework structures in the light chain variable domain. , 1993, Journal of immunological methods.

[18]  L. Björck,et al.  Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. , 1992, The Journal of biological chemistry.

[19]  L. Björck,et al.  Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. , 1992, The Journal of biological chemistry.

[20]  L. Björck.  Protein L. A novel bacterial cell wall protein with affinity for Ig L chains. , 1988, Journal of Immunology.

[21]  E. Myhre,et al.  A non-immune interaction between the light chain of human immunoglobulin and a surface component of a Peptococcus magnus strain. , 1985, Molecular immunology.

[22]  S. Bottomley,et al.  Cloning, expression and purification of Ppl-1, a kappa-chain binding protein, based upon protein L from Peptostreptococcus magnus. , 1995, Bioseparation.